Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
Michele Bartoletti, Roberta Mazzeo, Marco de Scordilli, Anna Del Fabro, Maria Grazia Vitale, L. Bortot, Milena S. Nicoloso, Serena Corsetti, Marta Bonotto, Simona Scalone, Giorgio Giorda, Roberto Sorio, Claudia Andreetta, M. Meacci, Rocco De Vivo, Gianpiero Fasola, Francesco Sopracordevole, Fabio Puglisi
Topics & Concepts
MedicineExtramammary Paget's diseaseVulvaHuman Epidermal Growth Factor Receptor 2Epidermal growth factorDermatologyEpidermal growth factor receptorCancer researchPaget DiseaseOncologyDiseaseReceptorInternal medicineCancerBreast cancerCancer and Skin LesionsHair Growth and DisordersMale Breast Health Studies